| P50 | author | Manho Kim | Q55728067 |
| | Soon-Tae Lee | Q79665386 |
| | Kon Chu | Q86742155 |
| P2093 | author name string | Seung U Kim | |
| P2860 | cites work | Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway | Q24558745 |
| | A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 |
| | Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease | Q28114818 |
| | Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes | Q28189644 |
| | Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation | Q28246858 |
| | Stem cells for the treatment of neurological disorders | Q28249501 |
| | Normal huntingtin function: an alternative approach to Huntington's disease | Q28281904 |
| | Mammalian neural stem cells | Q29547657 |
| | Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. | Q31033640 |
| | Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. | Q31118947 |
| | Mutant huntingtin enhances excitotoxic cell death. | Q31847067 |
| | Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury | Q33202586 |
| | Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice | Q33216927 |
| | Glutamine repeats and neurodegenerative diseases: molecular aspects | Q33546888 |
| | Differential loss of striatal projection neurons in Huntington disease | Q33637273 |
| | Cell replacement therapies for central nervous system disorders. | Q33921503 |
| | FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease | Q34212651 |
| | Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum | Q34261852 |
| | Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid | Q34384772 |
| | Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. | Q34433743 |
| | Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4 | Q34770039 |
| | Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain | Q35171498 |
| | Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology | Q35579484 |
| | Graft-induced behavioral recovery in an animal model of Huntington disease | Q35601129 |
| | Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 |
| | Human neural stem cells genetically modified for brain repair in neurological disorders | Q35918287 |
| | Cell therapy in Huntington's disease. | Q36045364 |
| | Anatomy and connectivity of intrastriatal striatal transplants | Q36128632 |
| | 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. | Q36318579 |
| | Gene therapy: can neural stem cells deliver? | Q36350210 |
| | The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies | Q36358871 |
| | Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease | Q36417361 |
| | Excitotoxic injury of the neostriatum: a model for Huntington's disease | Q36586040 |
| | Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea | Q39109797 |
| | Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease. | Q39145436 |
| | Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma | Q40131868 |
| | Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model | Q40184078 |
| | Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. | Q40202809 |
| | Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease | Q40278367 |
| | Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease | Q40356743 |
| | PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model | Q40382315 |
| | Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. | Q40394957 |
| | Distribution and in situ proliferation patterns of intravenously injected immortalized human neural stem-like cells in rats with focal cerebral ischemia | Q40487319 |
| | Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease | Q40506280 |
| | Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease | Q40543499 |
| | Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract | Q41182414 |
| | Human neural stem cell transplants improve motor function in a rat model of Huntington's disease | Q42463574 |
| | Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment. | Q42488000 |
| | Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression | Q42835214 |
| | Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery | Q44115092 |
| | Striatal neural grafting improves cortical metabolism in Huntington's disease patients | Q44649029 |
| | Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia | Q44972813 |
| | The quinolinic acid model of Huntington's disease: locomotor abnormalities | Q45021251 |
| | Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats | Q45063826 |
| | Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes | Q45289644 |
| | A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats | Q45289978 |
| | Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea | Q45291572 |
| | Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations | Q45294365 |
| | Safety of intrastriatal neurotransplantation for Huntington's disease patients | Q45295583 |
| | The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain | Q45296613 |
| | Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model | Q45296899 |
| | Striatal transplantation in a transgenic mouse model of Huntington's disease | Q45297047 |
| | Selective sparing of a class of striatal neurons in Huntington's disease | Q45297134 |
| | Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion | Q45299179 |
| | Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease | Q45299926 |
| | Motor and cognitive improvements in patients with Huntington's disease after neural transplantation | Q45301920 |
| | Anterior cingulate cortical transplantation in transgenic Huntington's disease mice | Q45304732 |
| | Reversal of long-term locomotor abnormalities in the kainic acid model of huntington's disease by day 18 fetal striatal implants | Q45304974 |
| | Bilateral human fetal striatal transplantation in Huntington's disease. | Q45305502 |
| | Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats | Q45307246 |
| | Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage | Q48244314 |
| | Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats | Q48675224 |
| P433 | issue | 1 | |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 1-9 | |
| P577 | publication date | 2007-12-05 | |
| P1433 | published in | Neuropathology | Q15761930 |
| P1476 | title | Stem cell-based cell therapy for Huntington disease: a review | |
| P478 | volume | 28 | |